Selective regulation of cyclic nucleotide phosphodiesterase PDE3A isoforms

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 49, 2013, Pages 19778-19783

  Vandeput, Fabrice ^a,b,c   Szabo Fresnais, Nicolas ^a,b,c   Ahmad, Faiyaz ^d   Kho, Changwon ^e   Lee, Ahyoung ^e   Krall, Judith ^a,b,c   Dunlop, Allan ^f   Hazel, Mark W ^a,b,c   Wohlschlegel, James A ^g   Hajjar, Roger J ^e   Houslay, Miles D ^h   Manganiello, Vincent C ^d   Movsesian, Matthew A ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

CAMP; Protein protein interactions

Indexed keywords

CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 3A1; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES 3A2; HYDROLASE; ISOPRENALINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOSOLIC FRACTION; GEL FILTRATION CHROMATOGRAPHY; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INOTROPISM; INTRACELLULAR MEMBRANE; INTRACELLULAR SIGNALING; MICROSOME; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 84889660239     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1305427110     Document Type: Article

References (32)

1. Beca S, et al. (2013) Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heart. Circ Res 112(2):289-297.
2. Frank KF, Bölck B, Brixius K, Kranias EG, Schwinger RH (2002) Modulation of ERCA: Implications for the failing human heart. Basic Res Cardiol 97(Suppl 1):I72-I78.
3. Kamp TJ, Hell JW (2000) Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 87(12):1095-1102.
4. Meissner G (2004) Molecular regulation of cardiac ryanodine receptor ion channel. Cell Calcium 35(6):621-628.
5. Marx SO, Marks AR (2002) Regulation of the ryanodine receptor in heart failure. Basic Res Cardiol 97(Suppl 1):I49-I51.
6. Amsallem E, Kasparian C, Haddour G, Boissel JP, Nony P (2005) Phosphodiesterase 3 inhibitors for heart failure. Cochrane Database Syst Rev (1):CD002230.
7. Ding B, et al. (2005) Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: Implication in heart failure. Circulation 111(19):2469-2476.
8. Ding B, et al. (2005) A positive feedback loop of phosphodiesterase 3 (PDE3) and inducible cAMP early repressor (ICER) leads to cardiomyocyte apoptosis. Proc Natl Acad Sci USA 102(41):14771-14776.
9. Yan C, Miller CL, Abe J (2007) Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart. Circ Res 100(4):489-501.
10. Wechsler J, et al. (2002) Isoforms of cyclic nucleotide phosphodiesterase PDE3A in cardiac myocytes. J Biol Chem 277(41):38072-38078.
11. Kenan Y, Murata T, Shakur Y, Degerman E, Manganiello VC (2000) Functions of the N-terminal region of cyclic nucleotide phosphodiesterase 3 (PDE 3) isoforms. J Biol Chem 275(16):12331-12338.
12. Shakur Y, et al. (2000) Membrane localization of cyclic nucleotide phosphodiesterase 3 (PDE3): Two N-terminal domains are required for the efficient targeting to, and association of, PDE3 with endoplasmic reticulum. J Biol Chem 275(49):38749-38761.
13. Hambleton R, et al. (2005) Isoforms of cyclic nucleotide phosphodiesterase PDE3 and their contribution to cAMP hydrolytic activity in subcellular fractions of human myocardium. J Biol Chem 280(47):39168-39174.
14. Pozuelo Rubio M, Campbell DG, Morrice NA, Mackintosh C (2005) Phosphodiesterase 3A binds to 14-3-3 proteins in response to PMA-induced phosphorylation of Ser428. Biochem J 392(Pt 1):163-172.
15. Hunter RW, Mackintosh C, Hers I (2009) Protein kinase C-mediated phosphorylation and activation of PDE3A regulate cAMP levels in human platelets. J Biol Chem 284(18):12339-12348.
16. Onuma H, et al. (2002) Identification of the insulin-regulated interaction of phosphodiesterase 3B with 14-3-3 beta protein. Diabetes 51(12):3362-3367.
17. Palmer D, et al. (2007) Protein kinase A phosphorylation of human phosphodiesterase 3B promotes 14-3-3 protein binding and inhibits phosphatase-catalyzed inactivation. J Biol Chem 282(13):9411-9419.
18. Macphee CH, Reifsnyder DH, Moore TA, Lerea KM, Beavo JA (1988) Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets. J Biol Chem 263(21):10353-10358.
19. Grant PG, Mannarino AF, Colman RW (1988) cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity. Proc Natl Acad Sci USA 85(23):9071-9075.
20. Han SJ, et al. (2006) Protein kinase B/Akt phosphorylation of PDE3A and its role in mammalian oocyte maturation. EMBO J 25(24):5716-5725.
21. Zaccolo M, Pozzan T (2002) Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 295(5560):1711-1715.
22. Ahmad F, et al. (2007) Insulin-induced formation of macromolecular complexes involved in activation of cyclic nucleotide phosphodiesterase 3B (PDE3B) and its interaction with PKB. Biochem J 404(2):257-268.
23. Ahmad F, et al. (2009) Differential regulation of adipocyte PDE3B in distinct membrane compartments by insulin and the beta3-adrenergic receptor agonist CL316243: Effects of caveolin-1 knockdown on formation/maintenance of macromolecular signaling complexes. Biochem J 424(3):399-410.
24. Choi YH, et al. (2001) Identification of a novel isoform of the cyclic-nucleotide phosphodiesterase PDE3A expressed in vascular smooth-muscle myocytes. Biochem J 353(Pt 1):41-50.
25. 2(+) flux at the endoplasmic reticulum and plasma membranes of HEK293 and Jurkat cells. Cell Signal 23(2):497-505.
26. Mackintosh C (2004) Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. Biochem J 381(Pt 2):329-342.
27. Johnson C, et al. (2010) Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem J 427(1):69-78.
28. Saha M, et al. (2012) RSK phosphorylates SOS1 creating 14-3-3-docking sites and negatively regulating MAPK activation. Biochem J 447(1):159-166.
29. Muslin AJ, Xing H (2000) 14-3-3 proteins: Regulation of subcellular localization by molecular interference. Cell Signal 12(11-12):703-709.
30. Ghigo A, et al. (2012) Phosphoinositide 3-kinase γ protects against catecholamineinduced ventricular arrhythmia through protein kinase A-mediated regulation of distinct phosphodiesterases. Circulation 126(17):2073-2083.
31. Vandeput F, et al. (2009) cGMP-hydrolytic activity and its inhibition by sildenafil in normal and failing human and mouse myocardium. J Pharmacol Exp Ther 330(3): 884- 891.
32. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248- 254.